886644673	886644673	CD	B-NP	O
|	|	NNP	I-NP	O
RHHS	RHHS	NNP	I-NP	O
|	|	VBD	B-VP	O
71070253	71070253	CD	B-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
9643226	9643226	CD	B-NP	O
|	|	CC	I-NP	O
6/10/2005	6/10/2005	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Summary	Summary	NNP	I-NP	O
|	|	NNP	I-NP	O
Signed	Signed	NNP	I-NP	O
|	|	NNP	I-NP	O
DIS	DIS	NNP	I-NP	O
|	|	NNP	I-NP	O
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
1/1/2005	1/1/2005	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Signed	Signed	NNP	B-NP	O
Discharge	Discharge	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
ATTENDING	ATTENDING	NN	B-NP	O
:	:	:	O	O
LAFACE	LAFACE	NN	B-NP	O
,	,	,	O	O
GARRET	GARRET	NNP	B-NP	O
CAREY	CAREY	NNP	I-NP	O
MD	MD	NNP	I-NP	O
ADDENDUM	ADDENDUM	NNP	I-NP	O
INTERIM	INTERIM	NNP	I-NP	O
HOSPITAL	HOSPITAL	NNP	I-NP	O
COURSE	COURSE	NNP	I-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
was	be	VBD	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NNP	B-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
60	60	CD	B-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
b.i.d.	b.i.d.	FW	I-ADVP	O
given	give	VBN	B-PP	O
his	his	PRP$	B-NP	O
low	low	JJ	I-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

However	However	RB	B-ADVP	O
,	,	,	O	O
he	he	PRP	B-NP	O
is	be	VBZ	B-VP	O
maintained	maintain	VBN	I-VP	O
on	on	IN	B-PP	O
this	this	DT	B-NP	O
dose	dose	NN	I-NP	O
without	without	IN	B-PP	O
hold	hold	NN	B-NP	O
parameters	parameter	NNS	I-NP	O
given	give	VBN	B-VP	O
his	his	PRP$	B-NP	O
third	third	JJ	I-NP	O
spacing	spacing	NN	I-NP	O
of	of	IN	B-PP	O
fluids	fluid	NNS	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
remained	remain	VBD	B-VP	O
in	in	IN	B-PP	O
the	the	DT	B-NP	O
high	high	JJ	I-NP	O
80s	80s	CD	I-NP	O
to	to	TO	B-PP	O
low	low	JJ	B-NP	O
100s	100	NNS	I-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
nadolol	nadolol	NN	I-NP	O
had	have	VBD	B-VP	O
been	be	VBN	I-VP	O
held	hold	VBN	I-VP	O
and	and	CC	O	O
was	be	VBD	B-VP	O
decreased	decrease	VBN	I-VP	O
to	to	TO	B-PP	O
20	20	CD	B-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
to	to	TO	B-VP	O
be	be	VB	I-VP	O
given	give	VBN	I-VP	O
only	only	RB	B-ADVP	O
if	if	IN	B-SBAR	O
his	his	PRP$	B-NP	O
blood	blood	NN	I-NP	O
pressure	pressure	NN	I-NP	O
is	be	VBZ	B-VP	O
greater	great	JJR	B-ADJP	O
than	than	IN	B-PP	O
95	95	CD	B-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
lactulose	lactulose	NN	B-NP	O
.	.	.	O	O

His	His	PRP$	B-NP	O
methadone	methadone	NN	I-NP	O
was	be	VBD	B-VP	O
increased	increase	VBN	I-VP	O
to	to	TO	B-PP	O
30	30	CD	B-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
for	for	IN	B-PP	O
control	control	NN	B-NP	O
of	of	IN	B-PP	O
his	his	PRP$	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

In	In	IN	B-PP	O
addition	addition	NN	B-NP	O
,	,	,	O	O
he	he	PRP	B-NP	O
was	be	VBD	B-VP	O
placed	place	VBN	I-VP	O
on	on	IN	B-PP	O
MSIR	MSIR	NN	B-NP	O
15-30	15-30	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
3h	3h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
was	be	VBD	B-VP	O
given	give	VBN	I-VP	O
Neosporin	Neosporin	NN	B-NP	O
topical	topical	JJ	B-ADJP	O
for	for	IN	B-PP	O
scrotal	scrotal	JJ	B-NP	O
swelling	swelling	NN	I-NP	O
and	and	CC	O	O
minor	minor	JJ	B-NP	O
multiple	multiple	JJ	I-NP	O
abrasions	abrasion	NNS	I-NP	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
scrotum	scrotum	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
Skilled	Skille	VBN	B-NP	O
Nursing	Nurse	VBG	I-NP	O
Facility	Facility	NN	B-NP	O
with	with	IN	B-PP	O
hospice	hospice	NN	B-NP	O
care	care	NN	I-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
Dulcolax	Dulcolax	NN	B-NP	O
10	10	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
p.r.n.	p.r.n.	NN	I-NP	O
,	,	,	O	O
folate	folate	VB	B-VP	O
1	1	CD	B-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NNP	B-NP	O
,	,	,	O	O
Lasix	Lasix	NNP	B-NP	O
60	60	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
b.i.d.	b.i.d.	FW	I-NP	O
,	,	,	O	O
Motrin	Motrin	NNP	B-NP	O
600	600	CD	I-NP	O
p.r.	p.r.	NN	I-NP	O
q.	q.	NN	I-NP	O
6h	6h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-LST	O
pain	pain	NN	B-NP	O
,	,	,	O	O
NPH	NPH	NN	B-NP	B-protein
8	8	CD	I-NP	I-protein
units	unit	NNS	I-NP	O
q.a.m.	q.a.m.	NN	I-NP	O
and	and	CC	O	O
15	15	CD	B-NP	O
q.p.m.	q.p.m.	NN	I-NP	O
,	,	,	O	O
Regular	Regular	JJ	B-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
,	,	,	O	O
lactulose	lactulose	NN	B-NP	O
60	60	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	FW	I-NP	O
4h	4h	NN	I-NP	O
.	.	.	O	O

titrated	titrate	VBN	B-NP	O
four	four	CD	I-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
per	per	IN	B-PP	O
day	day	NN	B-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
30	30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
t.i.d.	t.i.d.	NN	I-NP	O
,	,	,	O	O
nadolol	nadolol	NN	B-NP	O
20	20	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
,	,	,	O	O
hold	hold	VBP	B-VP	O
if	if	IN	B-SBAR	O
SBP	SBP	NN	B-NP	B-protein
less	less	JJR	B-NP	O
than	than	IN	I-NP	O
95	95	CD	I-NP	O
or	or	CC	I-NP	O
heart	heart	NN	I-NP	O
rate	rate	NN	I-NP	O
less	less	JJR	B-ADJP	O
than	than	IN	B-PP	O
55	55	CD	B-NP	O
,	,	,	O	O
nicotine	nicotine	NN	B-NP	O
40	40	CD	I-NP	O
mg	mg	NN	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
topical	topical	JJ	I-NP	O
q.	q.	NN	I-NP	O
25h	25h	NN	I-NP	O
.	.	.	O	O

,	,	,	O	O
multivitamin	multivitamin	NN	B-NP	O
one	one	CD	I-NP	O
tab	tab	NN	I-NP	O
p.o.	p.o.	NN	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
thiamine	thiamine	NN	B-NP	O
100	100	CD	I-NP	O
p.o.	p.o.	FW	B-ADVP	O
q.d.	q.d.	FW	I-ADVP	O
,	,	,	O	O
Neosporin	Neosporin	NN	B-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
MSIR	MSIR	NN	B-NP	O
15-30	15-30	CD	I-NP	O
mg	mg	NN	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.	q.	NN	I-NP	O
3h	3h	NN	I-NP	O
.	.	.	O	O

p.r.n.	p.r.n.	LS	B-NP	O
pain	pain	NN	I-NP	O
hold	hold	NN	I-NP	O
if	if	IN	B-SBAR	O
oversedation	oversedation	NN	B-NP	O
,	,	,	O	O
miconazole	miconazole	NN	B-NP	O
powder	powder	NN	I-NP	O
topical	topical	JJ	I-NP	O
b.i.d.	b.i.d.	NN	I-NP	O
,	,	,	O	O
Nexium	Nexium	NNP	B-NP	O
40	40	CD	I-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	NN	I-NP	O
,	,	,	O	O
magnesium	magnesium	NN	B-NP	O
oxide	oxide	NN	I-NP	O
400	400	CD	B-NP	O
p.o.	p.o.	FW	I-NP	O
q.d.	q.d.	FW	I-NP	O
and	and	CC	O	O
Maalox	Maalox	NNP	B-NP	O
p.r.n.	p.r.n.	FW	I-NP	O
upset	upset	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
continue	continue	VB	I-VP	O
his	his	PRP$	B-NP	O
Regular	Regular	JJ	I-NP	B-protein
Insulin	Insulin	NN	I-NP	I-protein
sliding	slide	VBG	B-VP	O
scale	scale	NN	B-NP	O
to	to	TO	B-VP	O
monitor	monitor	VB	I-VP	O
sugar	sugar	NN	B-NP	O
and	and	CC	O	O
wean	wean	VB	B-VP	O
down	down	RP	B-PRT	O
on	on	IN	B-PP	O
his	his	PRP$	B-NP	O
NPH	NPH	NN	I-NP	B-protein
as	as	IN	B-SBAR	O
needed	need	VBN	B-VP	O
.	.	.	O	O

Continue	Continue	JJ	B-NP	O
comfort	comfort	NN	I-NP	O
measures	measure	NNS	I-NP	O
,	,	,	O	O
wound	wound	NN	B-NP	O
care	care	NN	I-NP	O
,	,	,	O	O
methadone	methadone	NN	B-NP	O
and	and	CC	I-NP	O
morphine	morphine	NN	I-NP	O
as	as	RB	B-CONJP	O
well	well	RB	I-CONJP	O
as	as	IN	I-CONJP	O
MSIR	MSIR	NN	B-NP	B-protein
as	as	IN	B-PP	O
needed	need	VBN	B-VP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
Lasix	Lasix	NN	B-NP	O
for	for	IN	B-PP	O
comfort	comfort	NN	B-NP	O
for	for	IN	B-PP	O
peripheral	peripheral	JJ	B-NP	O
edema	edema	NN	I-NP	O
and	and	CC	I-NP	O
nadolol	nadolol	NN	I-NP	O
only	only	RB	B-VP	O
as	as	RB	I-VP	O
tolerated	tolerate	VBN	I-VP	O
by	by	IN	B-PP	O
blood	blood	NN	B-NP	O
pressure	pressure	NN	I-NP	O
.	.	.	O	O

He	He	PRP	B-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
continued	continue	VBN	I-VP	O
on	on	IN	B-PP	O
lactulose	lactulose	NN	B-NP	O
for	for	IN	B-PP	O
four	four	CD	B-NP	O
to	to	TO	I-NP	O
six	six	CD	I-NP	O
bowel	bowel	NN	I-NP	O
movements	movement	NNS	I-NP	O
a	a	DT	B-NP	O
day	day	NN	I-NP	O
as	as	IN	B-SBAR	O
tolerated	tolerate	VBN	B-VP	O
to	to	TO	B-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
his	his	PRP$	B-NP	O
hepatic	hepatic	JJ	I-NP	O
encephalopathy	encephalopathy	NN	I-NP	O
.	.	.	O	O

DISPOSITION	DISPOSITION	NN	B-NP	O
:	:	:	O	O
The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	I-VP	O
rehab	rehab	VB	I-VP	O
in	in	IN	B-PP	O
poor	poor	JJ	B-NP	O
condition	condition	NN	I-NP	O
with	with	IN	B-PP	O
poor	poor	JJ	B-NP	O
prognosis	prognosis	NN	I-NP	O
.	.	.	O	O

The	The	DT	B-NP	O
patient	patient	NN	I-NP	O
has	have	VBZ	B-VP	O
comfort	comfort	NN	B-NP	O
measures	measure	NNS	I-NP	O
only	only	RB	B-ADVP	O
.	.	.	O	O

eScription	eScription	NN	B-NP	O
document	document	NN	I-NP	O
:	:	:	O	O
2-4558223	2-4558223	CD	B-NP	O
CS	CS	NNP	I-NP	O
Dictated	Dictated	NNP	I-NP	O
By	By	NNP	I-NP	O
:	:	:	O	O
CHERN	CHERN	NNP	B-NP	O
,	,	,	O	O
LUKE	LUKE	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
DERAPS	DERAPS	NNP	B-NP	O
,	,	,	O	O
EDWARDO	EDWARDO	NNP	B-NP	O
MARION	MARION	NNP	I-NP	O
Dictation	Dictation	NNP	I-NP	O
ID	ID	NNP	I-NP	O
0754032	0754032	CD	I-NP	O
D	D	NNP	I-NP	O
:	:	:	O	O
2/7/05	2/7/05	CD	B-NP	O
T	T	NN	I-NP	O
:	:	:	O	O
2/7/05	2/7/05	CD	B-NP	O

